Autolus Therapeutics plc (AUTL)

Autolus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	123.83	227.38	239.57	382.44	310.34	153.3
Short-Term Investments	330.45	360.64	-	-	-	-
Cash & Short-Term Investments	454.28	588.02	239.57	382.44	310.34	153.3
Cash Growth	-35.65%	145.45%	-37.36%	23.23%	102.44%	-27.22%
Accounts Receivable	27.18	0.95	1.05	0.15	0.07	-
Other Receivables	51.41	47.3	23.5	28.82	26.18	29.69
Receivables	78.59	48.24	24.54	28.98	26.25	29.69
Inventory	23.94	4.14	-	-	-	-
Prepaid Expenses	13.07	15.21	8.64	12.34	8.71	10.21
Restricted Cash	1.51	1.43	0.77	0.33	0.34	0.79
Other Current Assets	2.86	3.89	1.79	1.7	1.31	3.01
Total Current Assets	574.25	660.93	275.3	425.77	346.95	196.98
Property, Plant & Equipment	125.09	105.05	95.65	58.42	52.32	89.68
Other Intangible Assets	12.93	12.37	-	-	0.07	0.16
Long-Term Deferred Tax Assets	2.4	3.24	3.06	2.08	1.83	1.75
Other Long-Term Assets	6.31	1.13	1.36	4.01	4.4	5.66
Total Assets	720.98	782.73	375.38	490.27	405.56	294.24
Accounts Payable	5.41	1.97	0.1	0.53	0.43	2.26
Accrued Expenses	49.22	51.8	39.05	40.4	23.51	27.08
Current Portion of Leases	3.28	3	5.05	5.04	4.45	3.59
Other Current Liabilities	8.15	3.98	0.53	0.39	0.16	0.7
Total Current Liabilities	68.15	60.74	44.74	46.37	28.55	33.63
Long-Term Debt	244.63	244.6	170.9	125.9	47.02	-
Long-Term Leases	61.26	49.63	47.91	19.22	16.55	50.57
Other Long-Term Liabilities	0.48	0.43	0.36	0.12	0.13	-
Total Liabilities	374.52	355.4	263.91	191.6	92.24	84.21
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	1,563	1,556	1,019	1,008	843.11	595.02
Retained Earnings	-1,217	-1,099	-878.56	-670.18	-521.34	-379.24
Comprehensive Income & Other	0.98	-29.06	-28.87	-38.78	-8.45	-5.74
Shareholders' Equity	346.46	427.33	111.47	298.67	313.32	210.03
Total Liabilities & Equity	720.98	782.73	375.38	490.27	405.56	294.24
Total Debt	309.17	297.23	223.87	150.16	68.01	54.16
Net Cash (Debt)	145.11	290.79	15.7	232.28	242.32	99.14
Net Cash Growth	-65.22%	1752.19%	-93.24%	-4.15%	144.43%	-46.24%
Net Cash Per Share	0.56	1.14	0.09	2.45	3.36	1.92
Filing Date Shares Outstanding	266.14	266.13	265.93	173.07	90.91	52.35
Total Common Shares Outstanding	266.14	266.12	174.1	173.07	90.91	52.35
Working Capital	506.1	600.19	230.57	379.41	318.4	163.35
Book Value Per Share	1.30	1.61	0.64	1.73	3.45	4.01
Tangible Book Value	333.53	414.95	111.47	298.67	313.26	209.87
Tangible Book Value Per Share	1.25	1.56	0.64	1.73	3.45	4.01
Machinery	56.52	50.42	38.37	35.98	38.92	27.76
Construction In Progress	36.23	19.64	12.54	13.19	2.44	14.32
Leasehold Improvements	15.44	14.12	12.73	11.69	14.9	10.63

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q